Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Overall Market Size
2.1 Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size: 2024 VS 2032
2.2 Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Players in Global Market
3.2 Top Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Companies Ranked by Revenue
3.3 Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Companies in Global Market, by Revenue in 2024
3.5 Global Companies Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Type
3.6 Tier 1, Tier 2, and Tier 3 Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size Markets, 2024 & 2032
4.1.2 Imaging Techniques
4.1.3 Diagnostic Tests
4.1.4 Biopsy
4.1.5 Others
4.2 Segmentation by Type - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue & Forecasts
4.2.1 Segmentation by Type - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2024 & 2032
5.1.2 Hospital Pharmacy
5.1.3 Online Channels
5.1.4 Retail Channels
5.1.5 Others
5.2 Segmentation by Application - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue & Forecasts
5.2.1 Segmentation by Application - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2024 & 2032
6.2 By Region - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2020-2025
6.2.2 By Region - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2026-2032
6.2.3 By Region - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2020-2032
6.3.2 United States Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.3.3 Canada Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.3.4 Mexico Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2020-2032
6.4.2 Germany Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.4.3 France Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.4.4 U.K. Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.4.5 Italy Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.4.6 Russia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.4.7 Nordic Countries Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.4.8 Benelux Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2020-2032
6.5.2 China Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.5.3 Japan Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.5.4 South Korea Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.5.5 Southeast Asia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.5.6 India Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2020-2032
6.6.2 Brazil Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.6.3 Argentina Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, 2020-2032
6.7.2 Turkey Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.7.3 Israel Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.7.4 Saudi Arabia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
6.7.5 UAE Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size, 2020-2032
7 Companies Profiles
7.1 Allergan plc
7.1.1 Allergan plc Corporate Summary
7.1.2 Allergan plc Business Overview
7.1.3 Allergan plc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.1.4 Allergan plc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.1.5 Allergan plc Key News & Latest Developments
7.2 Pfizer Inc
7.2.1 Pfizer Inc Corporate Summary
7.2.2 Pfizer Inc Business Overview
7.2.3 Pfizer Inc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.2.4 Pfizer Inc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.2.5 Pfizer Inc Key News & Latest Developments
7.3 Gilead Sciences
7.3.1 Gilead Sciences Corporate Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.3.4 Gilead Sciences Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.3.5 Gilead Sciences Key News & Latest Developments
7.4 Genfit SA
7.4.1 Genfit SA Corporate Summary
7.4.2 Genfit SA Business Overview
7.4.3 Genfit SA Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.4.4 Genfit SA Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.4.5 Genfit SA Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Corporate Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.5.4 Novartis AG Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.5.5 Novartis AG Key News & Latest Developments
7.6 Intercepts Pharmaceuticals
7.6.1 Intercepts Pharmaceuticals Corporate Summary
7.6.2 Intercepts Pharmaceuticals Business Overview
7.6.3 Intercepts Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.6.4 Intercepts Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.6.5 Intercepts Pharmaceuticals Key News & Latest Developments
7.7 Cadila Healthcare
7.7.1 Cadila Healthcare Corporate Summary
7.7.2 Cadila Healthcare Business Overview
7.7.3 Cadila Healthcare Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.7.4 Cadila Healthcare Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.7.5 Cadila Healthcare Key News & Latest Developments
7.8 Novo Nordisk
7.8.1 Novo Nordisk Corporate Summary
7.8.2 Novo Nordisk Business Overview
7.8.3 Novo Nordisk Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.8.4 Novo Nordisk Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.8.5 Novo Nordisk Key News & Latest Developments
7.9 Raptor Pharmaceutical Corp
7.9.1 Raptor Pharmaceutical Corp Corporate Summary
7.9.2 Raptor Pharmaceutical Corp Business Overview
7.9.3 Raptor Pharmaceutical Corp Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.9.4 Raptor Pharmaceutical Corp Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.9.5 Raptor Pharmaceutical Corp Key News & Latest Developments
7.10 Galmed Pharmaceuticals
7.10.1 Galmed Pharmaceuticals Corporate Summary
7.10.2 Galmed Pharmaceuticals Business Overview
7.10.3 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.10.4 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.10.5 Galmed Pharmaceuticals Key News & Latest Developments
7.11 Madrigal Pharmaceuticals
7.11.1 Madrigal Pharmaceuticals Corporate Summary
7.11.2 Madrigal Pharmaceuticals Business Overview
7.11.3 Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.11.4 Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.11.5 Madrigal Pharmaceuticals Key News & Latest Developments
7.12 Viking Therapeutics
7.12.1 Viking Therapeutics Corporate Summary
7.12.2 Viking Therapeutics Business Overview
7.12.3 Viking Therapeutics Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.12.4 Viking Therapeutics Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.12.5 Viking Therapeutics Key News & Latest Developments
7.13 Conatus Pharmaceuticals
7.13.1 Conatus Pharmaceuticals Corporate Summary
7.13.2 Conatus Pharmaceuticals Business Overview
7.13.3 Conatus Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.13.4 Conatus Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.13.5 Conatus Pharmaceuticals Key News & Latest Developments
7.14 NGM Biopharmaceuticals
7.14.1 NGM Biopharmaceuticals Corporate Summary
7.14.2 NGM Biopharmaceuticals Business Overview
7.14.3 NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.14.4 NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.14.5 NGM Biopharmaceuticals Key News & Latest Developments
7.15 CymaBay Therapeutics
7.15.1 CymaBay Therapeutics Corporate Summary
7.15.2 CymaBay Therapeutics Business Overview
7.15.3 CymaBay Therapeutics Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.15.4 CymaBay Therapeutics Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.15.5 CymaBay Therapeutics Key News & Latest Developments
7.16 Boehringer Ingelheim
7.16.1 Boehringer Ingelheim Corporate Summary
7.16.2 Boehringer Ingelheim Business Overview
7.16.3 Boehringer Ingelheim Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.16.4 Boehringer Ingelheim Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.16.5 Boehringer Ingelheim Key News & Latest Developments
7.17 Eli Lilly and Company
7.17.1 Eli Lilly and Company Corporate Summary
7.17.2 Eli Lilly and Company Business Overview
7.17.3 Eli Lilly and Company Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.17.4 Eli Lilly and Company Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.17.5 Eli Lilly and Company Key News & Latest Developments
7.18 Bristol Myers Squibb
7.18.1 Bristol Myers Squibb Corporate Summary
7.18.2 Bristol Myers Squibb Business Overview
7.18.3 Bristol Myers Squibb Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Major Product Offerings
7.18.4 Bristol Myers Squibb Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in Global Market (2020-2025)
7.18.5 Bristol Myers Squibb Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Opportunities & Trends in Global Market
Table 2. Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Drivers in Global Market
Table 3. Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Restraints in Global Market
Table 4. Key Players of Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics in Global Market
Table 5. Top Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Share by Companies, 2020-2025
Table 8. Global Companies Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Type
Table 9. List of Global Tier 1 Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2026-2032
Table 30. Allergan plc Corporate Summary
Table 31. Allergan plc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 32. Allergan plc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 33. Allergan plc Key News & Latest Developments
Table 34. Pfizer Inc Corporate Summary
Table 35. Pfizer Inc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 36. Pfizer Inc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 37. Pfizer Inc Key News & Latest Developments
Table 38. Gilead Sciences Corporate Summary
Table 39. Gilead Sciences Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 40. Gilead Sciences Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 41. Gilead Sciences Key News & Latest Developments
Table 42. Genfit SA Corporate Summary
Table 43. Genfit SA Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 44. Genfit SA Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 45. Genfit SA Key News & Latest Developments
Table 46. Novartis AG Corporate Summary
Table 47. Novartis AG Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 48. Novartis AG Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 49. Novartis AG Key News & Latest Developments
Table 50. Intercepts Pharmaceuticals Corporate Summary
Table 51. Intercepts Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 52. Intercepts Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 53. Intercepts Pharmaceuticals Key News & Latest Developments
Table 54. Cadila Healthcare Corporate Summary
Table 55. Cadila Healthcare Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 56. Cadila Healthcare Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 57. Cadila Healthcare Key News & Latest Developments
Table 58. Novo Nordisk Corporate Summary
Table 59. Novo Nordisk Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 60. Novo Nordisk Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 61. Novo Nordisk Key News & Latest Developments
Table 62. Raptor Pharmaceutical Corp Corporate Summary
Table 63. Raptor Pharmaceutical Corp Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 64. Raptor Pharmaceutical Corp Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 65. Raptor Pharmaceutical Corp Key News & Latest Developments
Table 66. Galmed Pharmaceuticals Corporate Summary
Table 67. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 68. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 69. Galmed Pharmaceuticals Key News & Latest Developments
Table 70. Madrigal Pharmaceuticals Corporate Summary
Table 71. Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 72. Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 73. Madrigal Pharmaceuticals Key News & Latest Developments
Table 74. Viking Therapeutics Corporate Summary
Table 75. Viking Therapeutics Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 76. Viking Therapeutics Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 77. Viking Therapeutics Key News & Latest Developments
Table 78. Conatus Pharmaceuticals Corporate Summary
Table 79. Conatus Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 80. Conatus Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 81. Conatus Pharmaceuticals Key News & Latest Developments
Table 82. NGM Biopharmaceuticals Corporate Summary
Table 83. NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 84. NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 85. NGM Biopharmaceuticals Key News & Latest Developments
Table 86. CymaBay Therapeutics Corporate Summary
Table 87. CymaBay Therapeutics Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 88. CymaBay Therapeutics Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 89. CymaBay Therapeutics Key News & Latest Developments
Table 90. Boehringer Ingelheim Corporate Summary
Table 91. Boehringer Ingelheim Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 92. Boehringer Ingelheim Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 93. Boehringer Ingelheim Key News & Latest Developments
Table 94. Eli Lilly and Company Corporate Summary
Table 95. Eli Lilly and Company Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 96. Eli Lilly and Company Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 97. Eli Lilly and Company Key News & Latest Developments
Table 98. Bristol Myers Squibb Corporate Summary
Table 99. Bristol Myers Squibb Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Offerings
Table 100. Bristol Myers Squibb Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue (US$, Mn) & (2020-2025)
Table 101. Bristol Myers Squibb Key News & Latest Developments
List of Figures
Figure 1. Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Product Picture
Figure 2. Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Segment by Type in 2024
Figure 3. Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Segment by Application in 2024
Figure 4. Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue in 2024
Figure 9. Segmentation by Type � Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2020-2032
Figure 13. By Region - Global Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2020-2032
Figure 14. By Country - North America Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2020-2032
Figure 15. United States Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2020-2032
Figure 19. Germany Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 20. France Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2020-2032
Figure 27. China Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 31. India Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2020-2032
Figure 33. Brazil Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Market Share, 2020-2032
Figure 36. Turkey Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue, (US$, Mn), 2020-2032
Figure 40. Allergan plc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Pfizer Inc Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Gilead Sciences Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Genfit SA Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Novartis AG Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Intercepts Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Cadila Healthcare Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Novo Nordisk Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Raptor Pharmaceutical Corp Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Viking Therapeutics Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Conatus Pharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. NGM Biopharmaceuticals Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. CymaBay Therapeutics Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. Boehringer Ingelheim Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 56. Eli Lilly and Company Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 57. Bristol Myers Squibb Non-Alcoholic Steatohepatitis Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Industry Market Size
